Table 1.
Diseases | Pseudogenes | Species | Tissues | Sponge Targets | Expression Pattern |
Overall Survival |
Potential Functions / Applications | References |
---|---|---|---|---|---|---|---|---|
HCC | ANXA2P2 | Homo Sapiens | Liver | - | Upregulated | Decline | Induces migration and invasion of HCC cells in vitro | Wang et al. (2019) 84 |
RACGAP1P | Homo Sapiens | Cell Line | miR-15-5p | Upregulated | Decline | Sequestrates miR-15-5p from RACGAP1; Activates RhoA/ERK signaling |
Wang et al. (2019) 85 | |
RP11-564D11.3 | Homo Sapiens | Liver | miR-9-5p; miR-101-3p; miR-200 family |
Upregulated | Decline | Sequestrates miR-9-5p, miR-101-3p, and miR-200 family to target VEGFA to initiate and promote HCC |
Song et al. (2019) 86 | |
SUMO1P3 | Homo Sapiens | Liver; Cell Line |
- | Upregulated | Decline | Promotes cell proliferation, migration, invasion and radiation resistant of HCC in vitro |
Zhou et al. (2019) 87 | |
UBE2CP3 | Homo Sapiens | Liver; Cell Line |
- | Upregulated | Decline | Induces angiogenesis functions of HUVECs by activating ERK/HIF-1α/p70S6K/VEGFA signaling |
Lin et al. (2018) 88 | |
OCT4-pg1 | Homo Sapiens | Liver; Cell Line |
- | Upregulated | - | Promotes proliferation of HCC cells by inducing activation of AKT |
Pan et al. (2018) 89 | |
OCT4-pg4 | Homo Sapiens | Liver; Cell Line |
miR-145 | Upregulated | Decline | Serves as a miR-145 decoy to increase its parental gene OCT4 expression to promote HCC |
Wang et al. (2013) 74 | |
PTENP1 | Homo Sapiens | Liver; Cell Line |
miR-193a-3p | Downregulated | Elevation | Sequestrates miR-193a-3p to suppress cell growth, migration and invasion of HCC via PTEN pathway |
Qian et al. (2017) 90 | |
UBE2CP3 | Homo Sapiens | Liver; Cell Line |
- | Upregulated | Decline | Promotes epithelial to mesenchymal transition (EMT) in vitro and in vivo |
Cao et al. (2017) 91 | |
INTS6P1 | Homo Sapiens | Liver; Cell Line |
miR-17-5p | Downregulated | - | Serves as a miR-17-5p decoy to induce its parental gene INTS6 expression to inhibit HCC |
Peng et al. (2015) 92 | |
E2F3P1 | Homo Sapiens | Liver | - | - | - | The A allele of rs9909601 in E3F3P1 is positively correlated with a better prognosis than the G allele |
Pan et al. (2014) 39 Liu et al. (2013) 93 |
|
BC | PTTG3P | Homo Sapiens | Breast | miR-129-5p; miR-376c-3p; miR-383-5p |
Upregulated | Decline | Serves as a miRNA decoy to exert an oncogenic role via a miRNA-mRNA regulatory network |
Lou et al. (2019) 94 |
PTENP1 | Homo Sapiens | Breast | - | Downregulated | - | Inhibits growth and migration and enhances doxorubicin sensitivity in ER-negative cells; Increases ER-positive cell growth and decreases ERα |
Yndestad et al. (2018) 95 | |
CKS1BP7 | Homo Sapiens | Breast | - | Upregulated | - | Interacts with IGF1R to enhance cell proliferation | Liu et al. (2018) 96 | |
CYP4Z2P | Homo Sapiens | Breast; Cell Line |
miR-125a-3p | Upregulated | - | Sequesters miR-125a-3p to trigger a hTERT-dependent apoptotic inhibition; Induces phosphorylation of ERK1/2 and PI3K/Akt to enhance tumor-angiogenesis |
Li et al. (2017) 97 Zheng et al. (2015) 98 Zheng et al. (2014) 99 |
|
HMGA1P7 | Homo Sapiens | Breast Cell Line |
miR-15; miR-16; miR-214; miR-761 |
Upregulated | - | Acts as a ceRNA to promote H19 and Igf2 expression to induce MCF-7 cell proliferation in vitro |
De Martino et al. (2016) 100 |
|
GC | NANOGP8 | Homo Sapiens | Cell Line | - | Upregulated | - | Binds to the promoter region of DBC1 to induce cell proliferation and suppress apoptosis |
Li et al. (2019) 101 |
GBAP1 | Homo Sapiens | Stomach | miR-212-3p | - | - | Serves as a miR-212-3p decoy to induce GBA; SNP rs2990245 in GBAP1 influences the DNA methylation status of its own promoter region |
Ma et al. (2019) 102 | |
PTENP1 | Homo Sapiens | Stomach; Cell Line |
- | Downregulated | - | G allele of rs7853346 in PTENP1 is negatively correlated with the risk of GC; Suppresses GC proliferation, migration and invasion |
Ge et al. (2017) 103 Guo et al. (2016) 104 |
|
OCT4-pg1 | Homo Sapiens | Stomach; Cell Line |
- | Upregulated | Decline | Elevates expression of various growth factors to enhance GC cell proliferation and angiogenesis |
Hayashi et al. (2015) 105 | |
SUMO1P3 | Homo Sapiens | Stomach | - | Upregulated | Decline | Positively correlates with GC growth, differentiation and lymphatic metastasis |
Mei et al. (2013) 10 | |
RCC | DUXAP8 | Homo Sapiens | Kidney; Cell Line |
- | Upregulated | Decline | Alters miR-126/CED-9 signaling to promote RCC cell proliferation and migration |
Huang et al. (2018) 106 |
ccRCC | PTENP1 | Homo Sapiens | Kidney; Cell Line |
miR-21 | Downregulated | Elevation | Serves as a miR-21 decoy to increase PTEN; Inhibits cell growth, migration, invasion and sensitivity to cisplatin and gemcitabine |
Yu et al. (2014) 107 |
LUAD | CSDAP1 | Homo Sapiens | Lung; Cell Line |
- | Upregulated | Decline | Positively correlates with LUAD occurrence, development and prognosis |
Xu et al. (2018) 108 |
CHIAP2 | Homo Sapiens | Lung; Cell Line |
miR-873-3p; miR-3614-5p |
Downregulated | - | Serves as a miRNA decoy to regulate NFATC2 or GSK3β in WNT signaling pathway |
Shang et al. (2019) 109 | |
NSCLC | DUXAP8 | Homo Sapiens | Lung; Cell Line |
- | Upregulated | Decline | Recruits LSD1 and EZH2 to the promoters of EGR1 and RHOB to enhance NSCLC malignant phenotypes | Sun et al. (2017) 110 |
DUXAP10 | Homo Sapiens | Lung; Cell Line |
- | Upregulated | Decline | Interacts with LSD1 to epigenetically silence LATS2 and RRAD to induce tumorigenesis in NSCLC |
Wei et al. (2017) 111 | |
CRC | MYLKP1 | Homo Sapiens | Colon; Cell Line |
- | Upregulated | - | Suppresses its parental gene MYLK expression; Two SNPs, rs12490683 and rs12497343 in MYLKP1 significantly elevate the risk of CRC |
Lynn et al. (2018) 112 Han et al. (2011) 80 |
SUMO1P3 | Homo Sapiens | Colon; Cell Line |
- | Upregulated | Decline | Induces expression of cyclin D1, Vimentin and VEGFA and decreases E-cadherin to promote tumorigenesis and angiogenesis of CRC |
Zhang et al. (2017) 113 | |
TPTE2P1 | Homo Sapiens | Colon; Cell Line |
- | Upregulated | Decline | Induces cell cycle progression and inhibits apoptosis of CRC cells in vitro and in vivo |
Dai et al. (2019) 114 | |
EEC | HMGA1P6 HMGA1P7 | Homo Sapiens | Endometrium | - | Upregulated | Decline | Positively correlates with expression of its parental gene HMGA1 and EEC progression | Palumbo Junior et al. (2019) 115 |
UCS | HMGA1P6 | Homo Sapiens | Uterus | let-7a; miR-26a; miR-16; miR-214 |
Upregulated | - | Serves as a miRNA decoy implicated in downregulation of the HMGA1-targeting miRNAs, contributing to HMGA1 overexpression |
Brunetti et al. (2019) 116 |
OCS | HMGA1P6 HMGA1P7 | Homo Sapiens | Ovary | let-7a; miR-26a; miR-16; miR-214 |
Upregulated | - | Serves as miRNA decoys implicated in downregulation of the HMGA1-targeting miRNAs, contributing to HMGA1 overexpression |
Esposito et al. (2014) 72 Brunetti et al. (2019) 116 |
GBM | DUXAP8 | Homo Sapiens | Brain; Cell Line |
- | Upregulated | Decline | Promotes cell proliferation and colony formation of GBM in vitro |
Zhao et al. (2019) 117 |
LGMNP1 | Homo Sapiens | Cell Line | - | Upregulated | - | Reduces DNA damage processes and apoptosis to help acquire radiotherapy resistance |
Xu et al. (2019) 118 | |
PT | HMGA1P6 HMGA1P7 | Homo Sapiens | Pituitary; Cell Line |
- | Upregulated | - | Serve as ceRNAs to induce parental gene HMGA1 expression and increase cell proliferation and migration | Esposito et al. (2015) 119 |
CC | OCT4-pg1 | Homo Sapiens | Cervix; Cell Line |
- | Upregulated | - | Induces cell proliferation and migration and inhibits apoptosis of CC cells in vitro and in vivo |
Yu et al. (2019) 120 |
PDAC | DUXAP8 | Homo Sapiens | Pancreas; Cell Line |
- | Upregulated | Decline | Serves as a scaffold for EZH2 and LSD1 to epigenetically silence CDKN1A and KLF2 |
Lian et al. (2018) 121 |
SUMO1P3 | Homo Sapiens | Pancreas; Cell Line |
- | Upregulated | Decline | Induces development of EMT to enhance cell proliferation, migration and invasion in vitro |
Tian et al. (2018) 122 | |
ESCC | TUSC2P | Homo Sapiens | Esophagus; Cell Line |
miR-17-5p; miR-520a-3p; miR-608; miR-611 |
Downregulated | Elevation | Plays a tumor suppressive role in a miRNA-binding manner to induce a cell growth and invasion inhibition | Liu et al. (2018) 123 |
FTH1P3 | Homo Sapiens | Esophagus; Cell Line |
- | Upregulated | - | Enhances cell proliferation, migration, and invasion by activating Sp1 and NF-κB |
Yang et al. (2018) 124 | |
DLBCL | Braf-rs1 | Murine | Spleen; Cell Line |
miR-134; miR-543; miR-653 |
Upregulated | Decline | Functions in a ceRNA manner to elevate BRAF expression and to regulate MAPK signaling and cell proliferation in vitro and in vivo |
Karreth et al. (2015) 73 |
BRAFP1 | Homo Sapiens | Spleen; Cell Line |
miR-30a; miR-182; miR-876; miR-590 |
Upregulated | Decline | Functions in a ceRNA manner to elevate BRAF expression and to regulate MAPK signaling and cell proliferation in vitro and in vivo |
Karreth et al. (2015) 73 | |
AML | OCT4-pg1 | Homo Sapiens | Blood | - | Downregulated | Elevation | Contributes to the diagnosis and prognosis of AML | Yi et al. (2019) 125 |
CML | OCT4-pg1 | Homo Sapiens | Cell Line | - | - | - | Interacts directly with OCT-4, SOX2, and NANOG and indirectly with ABC transporters |
Lettnin et al. (2019) 126 |
TC | HMGA1P6 HMGA1P7 | Homo Sapiens | Thyroid; Cell Line |
miR-15; miR-16; miR-214; miR-761 |
Upregulated | - | Serve as miRNA decoys to induce parental gene HMGA1 and cancer-related genes expression to promote malignant phenotypes of cells in vitro | Esposito et al. (2014) 72 |
OSCC | FTH1P3 | Homo Sapiens | Oral; Cell Line |
- | Upregulated | Decline | Promotes cell proliferation, migration and invasion by inducing PI3K/Akt/GSK3β/Wnt/β-catenin signaling |
Liu et al. (2018) 127 |
BA | ANXA2P3 | Homo Sapiens | Liver; Cell Line |
- | Upregulated | - | Induces cell cycle progression and growth but inhibits apoptosis by activating ANXA2/ANXA2P3 signaling | Nuerzhati et al. (2019) 128 |
SPE | HK2P1 | Homo Sapiens | Decidua; Cell Line |
miR-6887-3p | Downregulated | - | Promotes glycolytic metabolism, and HESC decidualization by sequestering miR-6887-3p | Lv et al. (2018) 129 |
PGK1P2 | Homo Sapiens | Decidua | miR-330-5p | Downregulated | - | Sequesters miR-330-5p to affect decidualization by regulating angiogenesis and glycolysis metabolism |
Tong et al. (2018) 130 | |
Schizophrenia | NDUFV2P1 | Homo Sapiens | Brain; Cell Line |
- | Upregulated | - | Negatively correlates with pre- and mature NDUFV2 and with CoI-driven cellular respiration |
Bergman et al. (2018) 131 |
ASD | lncLRFN5-10 | Homo Sapiens | Cell Line | - | Downregulated | - | Positively affects expression of non-deleted LRFN5 | Cappuccio et al. (2019) 132 |
OA | PMS2L2 | Homo Sapiens | Cell Line | miR-203 | Downregulated | - | Serves as a miR-203 decoy to block Wnt/β-catenin and JAK/STAT signaling pathway |
Li et al. (2019) 133 |
AD | PTENP1 | Homo Sapiens | Aorta; Cell Line |
miR-21 | Upregulated | - | Induces PTEN to promote apoptosis and to inhibit HASMC growth by competing for miR-21 |
Lai et al. (2019) 134 |
MM | PDIA3P | Homo Sapiens | Bone Marrow; Cell Line |
- | Upregulated | Decline | Interacts with c-Myc to bind to G6PD promoter and to induce PPP flux to affect cell growth and drug resistant | Yang et al. (2018) 135 |
Abbreviations: AD: aortic dissection; AML: acute myelocytic leukemia; ASD: autism spectrum disorder; BA: biliary atresia; BC: breast cancer; CC: cervical cancer; ccRCC: clear cell renal cell carcinoma; ceRNA: competing endogenous RNA; CML: chronic myelocytic leukemia; CRC: colorectal cancer; DLBCL: diffuse large B cell lymphoma; EEC: endometrioid endometrial carcinomas; EMT: epithelial to mesenchymal transition; ESCC: esophageal squamous cell carcinoma; GBM: glioblastoma; GC: gastric cancer; HASMC: human aortic smooth muscle cell; HCC: hepatocellular carcinoma; HESC: human endometrial stromal cell; HUVEC: human umbilical vein endothelial cell; LUAD: lung adenocarcinoma; miRNA: microRNA; MM: multiple myeloma; mRNA: messenger RNA; NSCLC: non-small cell lung cancer; OA: osteoarthritis; OCS: ovarian carcinosarcomas; OSCC: oral squamous cell carcinoma; PDAC: pancreatic ductal adenocarcinoma; PT: pituitary tumor; RCC: renal cell carcinoma; SNP: single nucleotide polymorphism; SPE: severe preeclampsia; TC: thyroid carcinoma; UCS: uterine carcinosarcomas.